Biophytis SA
DelistedCIK 1768946fmd_1KA5XEYXJKZKY52HVN0M32R6SWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2023, 6 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Research and development | 10 | 9 | 10 | 20 | 16 | 9 |
| Operating income | (14) | (16) | (14) | (27) | (23) | (14) |
| Interest expense | 0 | 1 | 2 | 3 | 3 | 2 |
| Income before taxes | (14) | (19) | (26) | (31) | (24) | (17) |
| Income tax expense | (0) | (0) | – | – | – | – |
| Net income from continuing operations | (14) | (19) | – | – | – | – |
| Net income | (14) | (19) | (26) | (31) | (24) | (17) |
| Net income to common shareholders | (14) | (19) | (26) | (31) | (24) | (17) |